| Novartis Pharma Schweiz AG - Opatanol, Augentropfen |
| 56175 | | 01 | | Opatanol | | Augentropfen | | S01GX09 | | Olopatadin | | 29.04.2003 | | |
|
| Composition |
| olopatadinum 1 mg ut olopatadini hydrochloridum, benzalkonii chloridum 0.1 mg, natrii chloridum, dinatrii phosphas dodecahydricus corresp. phosphas 3.34 mg, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua purificata, q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Collyre | | | | | | | | Principe actif | Concentr. |
|---|
| Olopatadine | 1 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Olopatadine | 1 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph | | | Aqua Purificata | | | Benzalkonium Chlorure | 0.1 mg/ml | | Disodium Phosphate Dodecahydrate | | | Sodium Chlorure | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 5 ml | 6.66 | 16.50 | B | LS | Non |
|
